Drug Watch
U.S. Census Changes Pose Serious Threat to Public Health” “U.S.
Proposed U.S. Census changes may seriously threaten public health by impacting health research and federal programs.
Subcutaneous Efgartigimod Improves Ocular Myasthenia Symptoms
Subcutaneous efgartigimod significantly improves ocular myasthenia symptoms, with III ADAPT OCULUS data showing less double vision and drooping eyelids.
New device treats Meibomian gland dysfunction
Meibomian gland dysfunction treatment may be improved with new device Meiboleyes, designed to address drawbacks of existing tools.
Beauty products linked to rising eye health risks
The Tear Film & Ocular Surface Society warns beauty products may worsen eye health risks, especially for those with ocular surface disease.
Elucid Secures $55M to Advance Cardiac Imaging
Cardiac imaging gets a $55 million lift as Elucid unveils Plaque‑IQ, a 3‑D CT plaque map that could transform diagnostics and attract…
MiniMed files FDA request for patch pump
MiniMed patch pump aims for FDA clearance as the company prepares to launch the MiniMed Fit next summer, challenging Insulet’s market lead…
Boston Scientific to discontinue angiographic catheters
Boston Scientific is discontinuing Imager II angiographic catheters due to a manufacturing defect that can cause the tip to detach. Learn about…
Cyberattack disrupts Boston Scientific manufacturing
The cyberattack manufacturing disruption at Boston Scientific has halted production and shipping, and the company has no timeline for full recovery.
Philips invests $33.7M to develop stroke robot
Philips invests $33.7 million to develop a stroke robot capable of autonomous mechanical thrombectomies, enhancing medical technology innovation.
FDA approves new Roche and Lilly Alzheimer’s tests
The FDA has officially approved new Alzheimer's tests from Roche and Lilly to assist clinicians in evaluating patients with early signs of…